These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9407431)

  • 1. Why is proteinuria such an important risk factor for progression in clinical trials?
    Jerums G; Panagiotopoulos S; Tsalamandris C; Allen TJ; Gilbert RE; Comper WD
    Kidney Int Suppl; 1997 Dec; 63():S87-92. PubMed ID: 9407431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of diabetic nephropathy in type 1 diabetic patients.
    Najafian B; Mauer M
    Diabetes Res Clin Pract; 2009 Jan; 83(1):1-8. PubMed ID: 19070384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy.
    Rosolowsky ET; Niewczas MA; Ficociello LH; Perkins BA; Warram JH; Krolewski AS
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S46-53. PubMed ID: 18849087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular changes in normo- and microalbuminuric patients with long-standing insulin-dependent diabetes mellitus.
    Fioretto P; Mauer M
    Adv Nephrol Necker Hosp; 1997; 26():247-63. PubMed ID: 8922136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the natural history of diabetic nephropathy.
    Pugliese G
    Acta Diabetol; 2014 Dec; 51(6):905-15. PubMed ID: 25297841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuminuric and non-albuminuric pathways to renal impairment in diabetes.
    Macisaac RJ; Jerums G
    Minerva Endocrinol; 2005 Sep; 30(3):161-77. PubMed ID: 16208306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria: clinical signficance and basis for therapy.
    Woo KT; Lau YK
    Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic nephropathy. A historical, clinical and diagnostic framework].
    Conti AA
    Minerva Med; 2002 Oct; 93(5):347-55. PubMed ID: 12410167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E; Horio M; Yamagata K; Iseki K; Hara S; Ura N; Kiyohara Y; Makino H; Hishida A; Matsuo S
    Hypertens Res; 2008 Mar; 31(3):433-41. PubMed ID: 18497462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy.
    White KE; Marshall SM; Bilous RW
    Nephrol Dial Transplant; 2008 Nov; 23(11):3539-45. PubMed ID: 18558622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.